Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALTEX INDUSTRIES INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.03
0.06
0.06
0.06
0.03
0.04
0.04
0.03
0.02
0.02
General and administrative
0.39
0.19
0.16
0.16
0.17
0.17
0.18
0.26
0.23
0.32
Operating expenses
0.21
0.18
0.2
0.18
0.18
0.19
0.27
0.24
0.33
Interest income
0.01
0.1
0.13
0.12
Other non-operating income
0
0.01
0.12
0.02
0.06
0.47
0.11
0.65
0.12
Income tax
0
0
0
0
0
0
0
0
0
Net income
-0.37
-0.13
-0.07
-0.03
-0.13
-0.08
0.31
-0.13
0.44
-0.19
EPS, basic
-0.03
-0.01
-0.01
0.00
-0.01
-0.01
EPS, diluted
-0.03
-0.01
-0.01
0.00
-0.01
-0.01
Shares, basic (weighted)
12.7
12.7
12.6
12.3
12.2
12.1
Shares, diluted (weighted)
12.7
12.7
12.6
12.3
12.2
12.1
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
2.47
2.35
2.27
2.27
2.14
2.04
2.36
2.23
2.66
2.55
Receivables
0
0
0
Other current assets
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.02
0.02
0.02
Total current assets
2.49
2.37
2.29
2.29
2.16
2.06
2.39
2.26
2.68
2.57
Property, plant and equipment
0.13
0.11
0.1
0.06
0.05
0.04
0.04
0.03
0.03
0.02
Lease right-of-use assets
0
0.17
0.1
0.07
0.05
0.02
0.15
Total assets
2.62
2.48
2.39
2.34
2.33
2.2
2.49
2.33
2.73
2.75
Accounts payable
0.01
0
0.01
0.01
0.01
0
0
0
0.01
0.01
Accrued liabilities
1.08
1.08
1.08
1.07
1.07
1.07
1.07
1.14
1.14
1.24
Total current liabilities
1.09
1.08
1.09
1.09
1.11
1.11
1.11
1.18
1.18
1.28
Lease liabilities
0
0.1
0.07
0.05
0.02
0
0.13
Total liabilities
1.09
1.08
1.09
1.09
1.21
1.18
1.16
1.2
1.18
1.4
Paid-in capital
13.8
13.8
13.8
13.8
13.8
13.8
13.8
13.7
13.7
13.7
Retained earnings
-12.4
-12.6
-12.6
-12.7
-12.8
-12.9
-12.6
-12.7
-12.3
-12.5
Treasury stock
0
0
Shareholders' equity
1.53
1.39
1.3
1.25
1.12
1.02
1.33
1.13
1.55
1.34
Total equity
1.53
1.39
1.3
1.25
1.12
1.02
1.33
1.13
1.55
1.34
Total liabilities and equity
2.62
2.48
2.39
2.34
2.33
2.2
2.49
2.33
2.73
2.75
Shares outstanding
12.7
12.6
12.4
12.2
12.1
12
12
11.3
11.2
11.2
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-0.37
-0.13
-0.07
-0.03
-0.13
-0.08
0.31
-0.13
0.44
-0.19
Depreciation and amortization
0.02
0.02
0.01
0.04
0.01
0.01
0.01
0.01
0
0
Change in receivables
-0
0
-0
-0
0
-0
0
-0
0
0
Change in payables
0.01
-0
0.01
-0
-0
-0.01
0
0
0
0
Cash from operations
-0.12
-0.11
-0.06
0.01
-0.12
-0.09
-0.13
-0.06
-0.08
-0.1
Cash from investing
0
0
0
0
0
0.45
0
0.53
0
Share buybacks
-0.02
-0.01
-0.02
-0.01
-0
-0.02
0
-0.07
-0.02
-0.01
Cash from financing
-0.02
-0.01
-0.02
-0.01
-0
-0.02
0
-0.07
-0.02
-0.01
Net change in cash
-0.13
-0.12
-0.08
-0.01
-0.13
-0.1
0.32
-0.13
0.42
-0.11
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.17 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Net margin
-419.0%
Net income / revenue.
Operating cash flow margin
-671.4%
Cash from operations / revenue.
Return on equity (ROE)
-6.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-3.3%
Net income / average total assets.
D&A / revenue
9.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-21.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-20.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-10.3%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y
-143.9%
Net income vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-13.2%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
0.3%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
3.7%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
0.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
3.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
3.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.97x
Current assets / current liabilities.
Quick ratio
1.94x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.94x
(Cash + short-term investments) / current liabilities.
Market cap + total debt - cash - short-term investments.
P/S
90.6x
Market cap / revenue.
P/B
1.48x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.48x
Market cap / tangible book value, when positive.
Earnings yield
-4.6%
Net income / market cap (the inverse of P/E).
What was ALTEX INDUSTRIES INC's revenue in fiscal 2025?
ALTEX INDUSTRIES INC reported revenue of $18.0K for fiscal 2025, 21.7% lower than the year before.
Was ALTEX INDUSTRIES INC profitable in fiscal 2025?
No. It reported a net loss of $192.0K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.